128 related articles for article (PubMed ID: 18024323)
1. Characterization of bone marrow lymphoid infiltrates after immunochemotherapy for follicular lymphoma.
Laurent C; de Paiva GR; Ysebaert L; Laurent G; March M; Delsol G; Brousset P
Am J Clin Pathol; 2007 Dec; 128(6):974-80. PubMed ID: 18024323
[TBL] [Abstract][Full Text] [Related]
2. T-cell lymphoid aggregates in bone marrow after rituximab therapy for B-cell follicular lymphoma: a marker of therapeutic efficacy?
Raynaud P; Caulet-Maugendre S; Foussard C; Salles G; Moreau A; Rossi JF; Patey M; Rousselet MC; Bene MC; Damotte D; Cornillet Lefebvre P; Martin A; Costes V;
Hum Pathol; 2008 Feb; 39(2):194-200. PubMed ID: 17949786
[TBL] [Abstract][Full Text] [Related]
3. Signal transducers and activators of transcription 5a-dependent cross-talk between follicular lymphoma cells and tumor microenvironment characterizes a group of patients with improved outcome after R-CHOP.
Taskinen M; Valo E; Karjalainen-Lindsberg ML; Hautaniemi S; Meri S; Leppä S
Clin Cancer Res; 2010 May; 16(9):2615-23. PubMed ID: 20388848
[TBL] [Abstract][Full Text] [Related]
4. LightCycler-based quantitative real-time PCR monitoring of patients with follicular lymphoma receiving rituximab in combination with conventional or high-dose cytotoxic chemotherapy.
Martin S; Fischer C; Free M; Kurreck B; Stockinger H; Fenk R; Arnold C; Kliszewski S; Meckenstock G; Haas R; Kronenwett R
Eur J Haematol; 2005 Apr; 74(4):282-92. PubMed ID: 15777339
[TBL] [Abstract][Full Text] [Related]
5. Differential gene expression in non-malignant tumour microenvironment is associated with outcome in follicular lymphoma patients treated with rituximab and CHOP.
Harjunpää A; Taskinen M; Nykter M; Karjalainen-Lindsberg ML; Nyman H; Monni O; Hemmer S; Yli-Harja O; Hautaniemi S; Meri S; Leppä S
Br J Haematol; 2006 Oct; 135(1):33-42. PubMed ID: 16925574
[TBL] [Abstract][Full Text] [Related]
6. Efficacious but insidious: a retrospective analysis of fludarabine-induced myelotoxicity using long-term culture-initiating cells in 100 follicular lymphoma patients.
Janikova A; Koristek Z; Vinklarkova J; Pavlik T; Sticha M; Navratil M; Kral Z; Vasova I; Mayer J
Exp Hematol; 2009 Nov; 37(11):1266-73. PubMed ID: 19654036
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of CD31-positive microvessel density in follicular lymphoma patients treated with immunochemotherapy.
Taskinen M; Jantunen E; Kosma VM; Bono P; Karjalainen-Lindsberg ML; Leppä S
Eur J Cancer; 2010 Sep; 46(13):2506-12. PubMed ID: 20630741
[TBL] [Abstract][Full Text] [Related]
8. Immunochemotherapy for Bcl-2 and MUM-negative aggressive primary cutaneous B-cell non-Hodgkin's lymphoma.
Colovic N; Jurisic V; Terzic T; Atkinson HD; Colovic M
Arch Dermatol Res; 2009 Oct; 301(9):689-92. PubMed ID: 19495780
[TBL] [Abstract][Full Text] [Related]
9. Do cytogenetic abnormalities precede morphologic abnormalities in a developing malignant condition?
Northup JK; Gadre SA; Ge Y; Lockhart LH; Velagaleti GV
Eur J Haematol; 2007 Feb; 78(2):152-6. PubMed ID: 17313561
[TBL] [Abstract][Full Text] [Related]
10. Follicular pattern of bone marrow involvement by follicular lymphoma.
Torlakovic E; Torlakovic G; Brunning RD
Am J Clin Pathol; 2002 Nov; 118(5):780-6. PubMed ID: 12428800
[TBL] [Abstract][Full Text] [Related]
11. High numbers of tumor-associated macrophages have an adverse prognostic value that can be circumvented by rituximab in patients with follicular lymphoma enrolled onto the GELA-GOELAMS FL-2000 trial.
Canioni D; Salles G; Mounier N; Brousse N; Keuppens M; Morchhauser F; Lamy T; Sonet A; Rousselet MC; Foussard C; Xerri L
J Clin Oncol; 2008 Jan; 26(3):440-6. PubMed ID: 18086798
[TBL] [Abstract][Full Text] [Related]
12. [Clinicopathologic analysis of intestinal follicular lymphoma first presenting with gastrointestinal symptoms].
Xie JL; Jin Y; Zheng XD; Wei XJ; Zhu H; Zheng YY; Zhang SH; Zhang YN; Chen GY; Zhou XG
Zhonghua Bing Li Xue Za Zhi; 2012 May; 41(5):320-5. PubMed ID: 22883671
[TBL] [Abstract][Full Text] [Related]
13. Langerhans' cell histiocytosis mimicking relapse in a patient with follicular lymphoma.
Gimeno E; Cervera M; Trampal C; Solano A; Villalba G; Serrano S; Besses C; Salar A
Ann Hematol; 2008 Aug; 87(8):675-6. PubMed ID: 18351339
[No Abstract] [Full Text] [Related]
14. CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.
Atanackovic D; Cao Y; Luetkens T; Panse J; Faltz C; Arfsten J; Bartels K; Wolschke C; Eiermann T; Zander AR; Fehse B; Bokemeyer C; Kroger N
Haematologica; 2008 Mar; 93(3):423-30. PubMed ID: 18287134
[TBL] [Abstract][Full Text] [Related]
15. Cyclin D1-positive diffuse large B-cell lymphoma.
Rodriguez-Justo M; Huang Y; Ye H; Liu H; Chuang SS; Munson P; Prada-Puentes C; Kim I; Du MQ; Bacon CM
Histopathology; 2008 Jun; 52(7):900-3. PubMed ID: 18494615
[No Abstract] [Full Text] [Related]
16. Progressive bicytopenia due to persistent parvovirus B19 infection after immunochemotherapy with fludarabine/cyclophosphamide and rituximab for relapsed B cell lymphoma.
Hartmann JT; Meisinger I; Kröber SM; Weisel K; Klingel K; Kanz L
Haematologica; 2006 Dec; 91(12 Suppl):ECR49. PubMed ID: 17194655
[TBL] [Abstract][Full Text] [Related]
17. [Follicular variant of peripheral T-cell lymphoma: a clinicopathologic and genetic study of 2 cases].
Zhan HQ; Zhu XZ; Li XQ; Zhou XY
Zhonghua Bing Li Xue Za Zhi; 2011 Jan; 40(1):32-6. PubMed ID: 21429356
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical patterns of reactive microenvironment are associated with clinicobiologic behavior in follicular lymphoma patients.
Alvaro T; Lejeune M; Salvadó MT; Lopez C; Jaén J; Bosch R; Pons LE
J Clin Oncol; 2006 Dec; 24(34):5350-7. PubMed ID: 17135637
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of diffuse large B-cell lymphosarcoma with involvement of bone marrow in an old female patient].
Zamiatina VI; Kravchenko SK; Giliazitdinova EA; Magomedova AU; Vorob'ev IA; Gotman LN; Kaplanskaia IB; Kesel'man SA; Obukhova TN; Sakhibov IaD; Shevelev AA; Kremenetskaia AM
Ter Arkh; 2008; 80(7):54-7. PubMed ID: 18763597
[No Abstract] [Full Text] [Related]
20. Intravascular large B-cell lymphoma: remission after rituximab-cyclophosphamide, doxorubicin, vincristine, and prednisolone chemotherapy.
Horváth B; Demeter J; Eros N; Hársing J; Csomor J; Matolcsy A; Bottlik G; Gyori G; Marschalkó M; Kárpáti S
J Am Acad Dermatol; 2009 Nov; 61(5):885-8. PubMed ID: 19632742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
